Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

A handful of states are targeting the technology at the same time the Trump administration is cutting research funding and ...

In early 2021, individual investors and institutions hurled money at Moderna stock as if future growth were unlimited.

A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...

Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine technology ...

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...

The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.

Freshfields has won a Düsseldorf regional court patent dispute on behalf of client Moderna against German COVID-19 vaccine inventors BioNTech and Pfizer. BioNTech, represented by Taylor Wessing ...

The Florida surgeon general in January called for a halt in the use of covid mRNA vaccines. And in Texas, Attorney General ...